NASDAQ:AEMD

Aethlon Medical Stock Forecast, Price & News

$4.90

+0.03 (+0.62 %)

(As of 07/30/2021 12:00 AM ET)

Add

Compare

Today's Range

$4.82

▼

$5.10

50-Day Range

$1.69

▼

$10.79

52-Week Range

$1.22

▼

$12.49

Volume310,331 shs

Average Volume1.75 million shs

Market Capitalization$75.36 million

P/E RatioN/A

Dividend YieldN/A

Beta0.65

30 days | 90 days | 365 days | Advanced Chart

Receive AEMD News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

About Aethlon Medical

Aethlon Medical, Inc. is a medical technology company, which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.

Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Drop in Short Interest
July 31, 2021 | americanbankingnews.com

Aethlon Medical to Release First Quarter...
July 29, 2021 | benzinga.com

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2021
July 29, 2021 | finance.yahoo.com

Sigyn Therapeutics Announces Successful Completion of Animal Pilot Study
July 29, 2021 | finance.yahoo.com

Aethlon Medical, Inc. Common Stock (AEMD)
July 23, 2021 | nasdaq.com

NUWE, MVO and NEGG among midday overs
July 22, 2021 | seekingalpha.com

Analyzing Surmodics (NASDAQ:SRDX) & Aethlon Medical (NASDAQ:AEMD)
July 19, 2021 | americanbankingnews.com

Traders Purchase Large Volume of Call Options on Aethlon Medical (NASDAQ:AEMD)
July 19, 2021 | americanbankingnews.com

Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update
July 16, 2021 | americanbankingnews.com

Looking Into Aethlon Medical's Return On Capital Employed
July 13, 2021 | benzinga.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AEMD
Previous Symbol
CUSIPN/A
CIK773910
Webwww.aethlonmedical.com
Phone(858) 459-7800
Employees8
Year FoundedN/A

Sales & Book Value

Annual Sales$660,000.00
Price / Sales114.18
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.77 per share
Price / Book6.36

Profitability

EPS (Most Recent Fiscal Year)($0.65)
Net Income$-7,890,000.00
Net MarginsN/A
Return on Equity-63.76%
Return on Assets-57.55%

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares15,380,000
Market Cap$75.36 million
Next Earnings Date8/9/2021 (Confirmed)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.78 out of 5 stars

Medical Sector

809th out of 2,220 stocks

Surgical & Medical Instruments Industry

86th out of 185 stocks

3.5 Analyst's Opinion

Consensus Rating
Aethlon Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $10.00, Aethlon Medical has a forecasted upside of 104.1% from its current price of $4.90.
Amount of Analyst Coverage
Aethlon Medical has only been the subject of 2 research reports in the past 90 days.

4.8 Community Rank

Outperform Votes
Aethlon Medical has received 212 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Aethlon Medical has received 85 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Aethlon Medical has received 71.38% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Aethlon Medical and other stocks. Vote “Outperform” if you believe AEMD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AEMD will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Aethlon Medical does not currently pay a dividend.
Dividend Growth
Aethlon Medical does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Aethlon Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.67% of the stock of Aethlon Medical is held by insiders.
Percentage Held by Institutions
Only 5.81% of the stock of Aethlon Medical is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Aethlon Medical are expected to grow in the coming year, from ($0.50) to $1.47 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Aethlon Medical is -7.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Aethlon Medical is -7.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Aethlon Medical has a P/B Ratio of 6.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Aethlon Medical (NASDAQ:AEMD) Frequently Asked Questions

Is Aethlon Medical a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Aethlon Medical stock.
View analyst ratings for Aethlon Medical or view top-rated stocks.

What stocks does MarketBeat like better than Aethlon Medical?

Wall Street analysts have given Aethlon Medical a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aethlon Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Aethlon Medical?

Aethlon Medical saw a drop in short interest in July. As of July 15th, there was short interest totaling 200,400 shares, a drop of 30.1% from the June 30th total of 286,500 shares. Based on an average daily volume of 5,780,000 shares, the days-to-cover ratio is presently 0.0 days.
View Aethlon Medical's Short Interest.

When is Aethlon Medical's next earnings date?

Aethlon Medical is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for Aethlon Medical.

How can I listen to Aethlon Medical's earnings call?

Aethlon Medical will be holding an earnings conference call on Monday, August 9th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "10159282".

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) announced its quarterly earnings data on Wednesday, June, 23rd. The medical equipment provider reported ($0.15) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.20) by $0.05. The medical equipment provider had revenue of $0.03 million for the quarter, compared to analysts' expectations of $0.46 million.
View Aethlon Medical's earnings history.

How has Aethlon Medical's stock price been impacted by COVID-19 (Coronavirus)?

Aethlon Medical's stock was trading at $1.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AEMD stock has increased by 146.2% and is now trading at $4.90.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for AEMD?

2 brokerages have issued 1 year target prices for Aethlon Medical's stock. Their forecasts range from $9.00 to $11.00. On average, they anticipate Aethlon Medical's stock price to reach $10.00 in the next year. This suggests a possible upside of 104.1% from the stock's current price.
View analysts' price targets for Aethlon Medical or view top-rated stocks among Wall Street analysts.

Who are Aethlon Medical's key executives?

Aethlon Medical's management team includes the following people:

Charles J. Fisher, Chief Executive Officer & Director
James B. Frakes, Chief Financial & Principal Accounting Officer
Annette Marleau, Research Director
Steven LaRosa, Chief Medical Officer
Guy F. Cipriani, Director, Chief Business Officer & Senior VP

Who are some of Aethlon Medical's key competitors?

Some companies that are related to Aethlon Medical include Profound Medical (PROF), The Westaim (WEDXF), Co-Diagnostics (CODX), DarioHealth (DRIO), Apollo Endosurgery (APEN), TELA Bio (TELA), Titan Medical (TMDI), Beyond Air (XAIR), Nemaura Medical (NMRD), T2 Biosystems (TTOO), Repro Med Systems (KRMD), RenovaCare (RCAR), BrainsWay (BWAY), PolyPid (PYPD) and Repro-Med Systems (REPR).
View all of AEMD's competitors.

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), OrganiGram (OGI), AT&T (T) and Aurora Cannabis (ACB).

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

How do I buy shares of Aethlon Medical?

Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $4.90.

How much money does Aethlon Medical make?

Aethlon Medical has a market capitalization of $75.36 million and generates $660,000.00 in revenue each year. The medical equipment provider earns $-7,890,000.00 in net income (profit) each year or ($0.65) on an earnings per share basis.

How many employees does Aethlon Medical have?

Aethlon Medical employs 8 workers across the globe.

What is Aethlon Medical's official website?

The official website for Aethlon Medical is www.aethlonmedical.com.

Where are Aethlon Medical's headquarters?

Aethlon Medical is headquartered at 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at [email protected]

This page was last updated on 8/1/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here